Sign In
Buy SNN
$29.61
+0.220 (+0.749%)
At Close: Jun 23, 2026
Smith & Nephew plc (SNN) Shareholder/Analyst Call Transcript
09:12am, Thursday, 11'th Jun 2026
Smith & Nephew plc (SNN) Shareholder/Analyst Call Transcript
Smith & Nephew's robotics push wins surgeon backing
11:30am, Wednesday, 10'th Jun 2026
Smith & Nephew PLC (LSE:SN) efforts to expand its surgical robotics platform and strengthen its orthopaedics pipeline received a vote of confidence from surgeons at a recent investor event, according
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, announces the completion of the first clinical cases performed using the next‑generation CORI◊ XT Handheld Robotics Platfo
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the US launch of next generation LEAF ♢ Patient Monitoring System, a data-driven pressure injury prevention platform
VEEV Boosts MedTech Quality Management With Smith+Nephew Partnership
01:25pm, Wednesday, 13'th May 2026
Veeva Systems expands its medtech reach as Smith+Nephew adopts Veeva Quality Cloud to modernize global quality operations and training.
Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call Transcript
09:02am, Wednesday, 06'th May 2026
Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call Transcript
UK's Smith+Nephew keeps annual outlook, plans share buyback as quarterly revenue rises
02:21am, Wednesday, 06'th May 2026
Medical products maker Smith+Nephew posted a 3.1% rise in first-quarter underlying revenue on Wednesday, helped by strong sports medicine and wound management performance, a
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an industry-leading portfolio set to showcase at the upcoming Europ
SNN vs. BSX: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 05'th May 2026
Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value oppo
SNN's CARTIHEAL Cartilage Implant Beats Standard Care in 5-Year Study
11:40am, Friday, 24'th Apr 2026
Smith+Nephew's CARTIHEAL implant shows superior 5-year outcomes vs. standard care, with a new CPT code set to boost adoption and expand cartilage repair reach.
Deprince Race & Zollo Inc. Purchases 36,072 Shares of Smith & Nephew SNATS, Inc. $SNN
04:30am, Tuesday, 14'th Apr 2026
Deprince Race and Zollo Inc. increased its position in shares of Smith and Nephew SNATS, Inc. (NYSE: SNN) by 10.6% in the undefined quarter, according to the company in its most recent 13F filing with
Results from the first-ever randomized control trial for the REGENETEN Implant in partial-thickness rotator cuff repair SmithNephew (LSE: SN, NYSE: SNN), the global medical technology company, today a
Barrow Hanley Mewhinney & Strauss LLC Sells 256,112 Shares of Smith & Nephew SNATS, Inc. $SNN
04:02am, Thursday, 12'th Mar 2026
Barrow Hanley Mewhinney and Strauss LLC cut its position in shares of Smith and Nephew SNATS, Inc. (NYSE: SNN) by 30.6% during the undefined quarter, according to the company in its most recent Form 1
SNN Launches ALLEVYN COMPLETE CARE Dressing for Wound Management
01:15pm, Wednesday, 11'th Mar 2026
Smith + Nephew launches ALLEVYN COMPLETE CARE foam dressing for wound management, expanding its Advanced Wound Management portfolio.
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, recently announced the launch of ALLEVYN♢ COMPLETE CARE Foam Dressing, featuring proprietary technologies and performance back
